Neuropsychological outcome following intensity‐modulated radiation therapy for pediatric medulloblastoma
- 17 April 2008
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 51 (2), 275-279
- https://doi.org/10.1002/pbc.21580
Abstract
Background Combined cisplatin chemotherapy and cranial irradiation for treatment of medulloblastoma in children can cause significant ototoxicity and impair cognitive function and quality of life. We have previously demonstrated the conformal technique of intensity‐modulated radiation therapy (IMRT) to reduce ototoxicity, however, it has been suggested that IMRT may increase risk of cognitive deficits compared to conventional radiation therapy (CRT). This study compared the impact of the two treatments on measures of neurocognitive functioning. Procedure Twenty‐five pediatric patients with medulloblastoma were treated either with CRT or IMRT. In addition they received neurocognitive assessments to evaluate long‐term functional outcome. Statistical analyses between the two groups were conducted to compare levels and profiles of performance on tests not confounded with hearing loss. Results When compared to CRT, children treated with IMRT did not perform more poorly on any of the measures. Both groups' mean performance was significantly lower than published norms on several of the measures employed. Conclusion The benefit of reduced ototoxicity with IMRT does not appear to be at the cost of a decline in nonverbal intellectual abilities, visual‐spatial skills, processing speed, or fine motor dexterity when compared to CRT in children with medulloblastoma. Pediatr Blood Cancer 2008;51:275–279.Keywords
This publication has 34 references indexed in Scilit:
- Neurocognitive Consequences of Risk-Adapted Therapy for Childhood MedulloblastomaJournal of Clinical Oncology, 2005
- Serial Evaluation of Academic and Behavioral Outcome After Treatment With Cranial Radiation in ChildhoodJournal of Clinical Oncology, 2005
- CNS‐directed therapy in young children with T‐lineage acute lymphoblastic leukemia: High‐dose methotrexate versus cranial irradiationPediatric Blood & Cancer, 2003
- Patterns of neuropsychological deficits in children with medulloblastoma according to craniospatial irradiation dosesDevelopmental Medicine and Child Neurology, 2000
- Evidence for the Syndrome of Nonverbal Learning Disabilities in Children with Brain TumorsChild Neuropsychology, 1998
- Radiotherapy Enhanced Ototoxicity of Cisplatin in ChildrenActa Oto-Laryngologica, 1997
- Association of 1800 cGy cranial irradiation with intellectual function in children with acute lymphoblastic leukaemiaThe Lancet, 1994
- The Nature and Structure of Children's Abilities: Evidence from the Differential Ability ScalesJournal of Psychoeducational Assessment, 1990
- Chromosome 22 breakpoints in variant Philadelphia translocations and Philadelphia-negative chronic myeloid leukemiaCancer Genetics and Cytogenetics, 1989
- Hearing loss in children receiving cisplatin chemotherapyThe Journal of Pediatrics, 1983